Payment overview · 2025
General Payments
$198.67
5 reported records · 4 companies
Healthcare provider profile · identity verified
Michael L Kondash, DO
Allopathic & Osteopathic Physicians|Family Medicine · SOUTH ABINGTON TOWNSHIP, PA · NPI 1710966536
Verified facts
What the public records show
CMS Open Payments records show Michael L Kondash, DO received $198.67 in general payments during 2025 across 5 reported records.
Novo Nordisk Inc accounted for 62.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 131 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Vraylar by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 141 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 119 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $125.00 | 62.9% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $34.73 | 17.5% | 2 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $21.58 | 10.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $17.36 | 8.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $198.67 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $34.73 | 2 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.58 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $17.36 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $13.49 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 141 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
131 | 30 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
141 | 29 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
119 | 22 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1561 | 336 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1493 | 281 |
| Eliquis | Apixaban | 1410 | 174 |
| Metoprolol Succinate | Metoprolol Succinate | 1252 | 237 |
| Amlodipine Besylate | Amlodipine Besylate | 1140 | 226 |
| Pantoprazole Sodium | Pantoprazole Sodium | 700 | 162 |
| Furosemide | Furosemide | 659 | 132 |
| Losartan Potassium | Losartan Potassium | 611 | 132 |
| Escitalopram Oxalate | Escitalopram Oxalate | 589 | 95 |
| Lisinopril | Lisinopril | 567 | 123 |
| Potassium Chloride | Potassium Chloride | 550 | 104 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 550 | 146 |
| Gabapentin | Gabapentin | 529 | 103 |
| Metoprolol Tartrate | Metoprolol Tartrate | 506 | 100 |
| Warfarin Sodium | Warfarin Sodium | 503 | 36 |
| Omeprazole | Omeprazole | 433 | 111 |
| Carvedilol | Carvedilol | 422 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 405 | 98 |
| Metformin Hcl | Metformin Hcl | 397 | 98 |
| Simvastatin | Simvastatin | 391 | 80 |
| Allopurinol | Allopurinol | 384 | 74 |
| Jardiance | Empagliflozin | 358 | 53 |
| Sertraline Hcl | Sertraline Hcl | 345 | 66 |
| Donepezil Hcl | Donepezil Hcl | 341 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 318 | 60 |
| Famotidine | Famotidine | 293 | 67 |
| Alprazolam | Alprazolam | 292 | 70 |
| Pravastatin Sodium | Pravastatin Sodium | 264 | 61 |
| Mirtazapine | Mirtazapine | 254 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 251 | 46 |
| Prednisone | Prednisone | 251 | 128 |
| Torsemide | Torsemide | 240 | 52 |
| Duloxetine Hcl | Duloxetine Hcl | 238 | 47 |
| Ezetimibe | Ezetimibe | 230 | 53 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 221 | 73 |
| Montelukast Sodium | Montelukast Sodium | 220 | 47 |
| Quetiapine Fumarate | Quetiapine Fumarate | 213 | 33 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 209 | 53 |
| Spironolactone | Spironolactone | 203 | 46 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 198 | 38 |
| Trazodone Hcl | Trazodone Hcl | 192 | 35 |
| Finasteride | Finasteride | 179 | 35 |
| Mounjaro | Tirzepatide | 175 | 42 |
| Levetiracetam | Levetiracetam | 173 | 26 |
| Pregabalin | Pregabalin | 173 | 47 |
| Methylprednisolone | Methylprednisolone | 170 | 114 |
| Memantine Hcl | Memantine Hcl | 159 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 158 | 35 |
| Irbesartan | Irbesartan | 147 | 37 |
| Tradjenta | Linagliptin | 144 | suppressed |
| Ozempic | Semaglutide | 141 | 29 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 140 | 26 |
| Tramadol Hcl | Tramadol Hcl | 136 | 44 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 135 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 133 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 132 | 51 |
| Synthroid | Levothyroxine Sodium | 131 | 30 |
| Verapamil Er | Verapamil Hcl | 128 | 31 |
| Lorazepam | Lorazepam | 125 | 33 |
| Buspirone Hcl | Buspirone Hcl | 124 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 124 | 18 |
| Breo Ellipta | Fluticasone/Vilanterol | 123 | 26 |
| Myrbetriq | Mirabegron | 122 | 21 |
| Xarelto | Rivaroxaban | 122 | 17 |
| Amoxicillin | Amoxicillin | 120 | 77 |
| Glimepiride | Glimepiride | 119 | 32 |
| Rybelsus | Semaglutide | 119 | 22 |
| Valsartan | Valsartan | 113 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 112 | 20 |
| Atenolol | Atenolol | 111 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 111 | 25 |
| Clonazepam | Clonazepam | 109 | 22 |
| Oxycodone Hcl | Oxycodone Hcl | 109 | 28 |
| Zolpidem Tartrate | Zolpidem Tartrate | 106 | 31 |
| Azithromycin | Azithromycin | 102 | 77 |
| Enalapril Maleate | Enalapril Maleate | 102 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 101 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 100 | 11 |
| Januvia | Sitagliptin Phosphate | 99 | 15 |
| Celecoxib | Celecoxib | 98 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 98 | 40 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 94 | 69 |
| Ondansetron Hcl | Ondansetron Hcl | 94 | 55 |
| Entresto | Sacubitril/Valsartan | 93 | 14 |
| Metformin Hcl Er | Metformin Hcl | 93 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 92 | 20 |
| Midodrine Hcl | Midodrine Hcl | 87 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 85 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 84 | 21 |
| Latanoprost | Latanoprost | 84 | 20 |
| Cephalexin | Cephalexin | 82 | 53 |
| Diclofenac Sodium | Diclofenac Sodium | 81 | 36 |
| Meloxicam | Meloxicam | 80 | 18 |
| Nystatin | Nystatin | 80 | 35 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 80 | 20 |
| Ketoconazole | Ketoconazole | 77 | 33 |
| Baclofen | Baclofen | 76 | 14 |
| Bupropion Xl | Bupropion Hcl | 73 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 73 | 56 |
| Trulicity | Dulaglutide | 73 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 72 | 19 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 72 | 56 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 72 | 15 |
| Bumetanide | Bumetanide | 71 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 69 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 68 | 15 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 67 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 65 | 35 |
| Metolazone | Metolazone | 62 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 60 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 60 | 14 |
| Topiramate | Topiramate | 60 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 58 | 17 |
| Ibuprofen | Ibuprofen | 58 | 23 |
| Labetalol Hcl | Labetalol Hcl | 58 | 11 |
| Lamotrigine | Lamotrigine | 58 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 56 | 17 |
| Enulose | Lactulose | 56 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 56 | 14 |
| Alendronate Sodium | Alendronate Sodium | 55 | 15 |
| Verapamil Sr | Verapamil Hcl | 54 | 14 |
| Silver Sulfadiazine | Silver Sulfadiazine | 52 | 23 |
| Calcium Acetate | Calcium Acetate | 51 | suppressed |
| Hydrocortisone | Hydrocortisone | 51 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 51 | 11 |
| Clobetasol Propionate | Clobetasol Propionate | 50 | 27 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 49 | 49 |
| Cefdinir | Cefdinir | 48 | 38 |
| Divalproex Sodium | Divalproex Sodium | 48 | 12 |
| Olanzapine | Olanzapine | 48 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 48 | suppressed |
| Ursodiol | Ursodiol | 48 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 47 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 47 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 47 | 11 |
| Sodium Chloride | 0.9 % Sodium Chloride | 47 | 25 |
| Bupropion Hcl Sr | Bupropion Hcl | 46 | 15 |
| Indapamide | Indapamide | 46 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 46 | 12 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 45 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 45 | 25 |
| Farxiga | Dapagliflozin Propanediol | 44 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 44 | 20 |
| Novolog Flexpen | Insulin Aspart | 44 | 13 |
| Valacyclovir | Valacyclovir Hcl | 44 | 30 |
| Doxycycline Hyclate | Doxycycline Hyclate | 43 | 27 |
| Methimazole | Methimazole | 43 | suppressed |
| Procrit | Epoetin Alfa | 43 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 42 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 42 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 42 | 41 |
| Vascepa | Icosapent Ethyl | 42 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 41 | suppressed |
| Fluconazole | Fluconazole | 40 | 23 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 39 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 39 | suppressed |
| Dutasteride | Dutasteride | 38 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 38 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 38 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | suppressed |
| Scopolamine | Scopolamine | 37 | suppressed |
| Sucralfate | Sucralfate | 37 | suppressed |
| Colchicine | Colchicine | 36 | 13 |
| Mometasone Furoate | Mometasone Furoate | 36 | 15 |
| Tresiba Flextouch U-100 | Insulin Degludec | 36 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 34 | 29 |
| Clozapine | Clozapine | 34 | suppressed |
| Repatha Sureclick | Evolocumab | 34 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 33 | 14 |
| Levofloxacin | Levofloxacin | 33 | 21 |
| Linzess | Linaclotide | 33 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 33 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 33 | suppressed |
| Budesonide | Budesonide | 32 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 32 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 31 | 21 |
| Loperamide | Loperamide Hcl | 31 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 29 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 29 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 29 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 28 | suppressed |
| Estradiol | Estradiol | 28 | suppressed |
| Lactulose | Lactulose | 28 | 11 |
| Praluent Pen | Alirocumab | 28 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 27 | 19 |
| Lovastatin | Lovastatin | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Metronidazole | Metronidazole | 27 | 13 |
| Ranolazine Er | Ranolazine | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | 13 |
| Glipizide | Glipizide | 26 | suppressed |
| Primidone | Primidone | 26 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 26 | suppressed |
| Brilinta | Ticagrelor | 25 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 12 |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Admelog | Insulin Lispro | 22 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Klor-Con M10 | Potassium Chloride | 22 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 22 | suppressed |
| Moxifloxacin Hcl | Moxifloxacin Hcl | 22 | 19 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 21 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 20 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 17 |
| Nyamyc | Nystatin | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 18 | 18 |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 18 | suppressed |
| Ssd | Silver Sulfadiazine | 18 | 13 |
| Lubiprostone | Lubiprostone | 17 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 17 | suppressed |
| Xultophy 100-3.6 | Insulin Degludec/Liraglutide | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 16 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 16 | 16 |
| Morphine Sulfate | Morphine Sulfate | 16 | suppressed |
| Novolog | Insulin Aspart | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Victoza 3-Pak | Liraglutide | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Np Thyroid | Thyroid,pork | 15 | suppressed |
| Repaglinide | Repaglinide | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 15 | suppressed |
| Dofetilide | Dofetilide | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 14 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Dulera | Mometasone/Formoterol | 13 | suppressed |
| Epinephrine | Epinephrine | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Metaxalone | Metaxalone | 13 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 13 | suppressed |
| Mirabegron Er | Mirabegron | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Acarbose | Acarbose | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 12 | suppressed |
| Alphagan P | Brimonidine Tartrate | 12 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Livalo | Pitavastatin Calcium | 12 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Felodipine Er | Felodipine | 11 | suppressed |
| Gemtesa | Vibegron | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Indomethacin | Indomethacin | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Pramipexole Er | Pramipexole Di-Hcl | 11 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $198.67 · 5 records | Novo Nordisk Inc | Ozempic, QULIPTA, The Cologuard Plus Collection Kit, UBRELVY, XIFAXAN | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error